Skip to main content
Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
22.32
+0.29 (1.32%)
At close: Mar 9, 2026, 4:00 PM EDT
22.76
+0.44 (1.97%)
After-hours: Mar 9, 2026, 4:06 PM EDT

Innoviva Market Cap

Innoviva has a market cap or net worth of $1.65 billion as of March 9, 2026. Its market cap has increased by 46.16% in one year.

Market Cap
1.65B
Enterprise Value
1.42B
1-Year Change
46.16%
Ranking
#2163
Category
Small-Cap
Stock Price
$22.32

Market Cap Chart

Since October 5, 2004, Innoviva's market cap has increased from $743.40M to $1.65B, an increase of 122.40%. That is a compound annual growth rate of 3.80%.

History

DateMarket Cap% Change
Mar 6, 20261.63B9.18%
Dec 31, 20251.49B37.61%
Dec 31, 20241.09B5.65%
Dec 29, 20231.03B11.18%
Dec 30, 2022924.60M-22.87%
Dec 31, 20211.20B-4.58%
Dec 31, 20201.26B-12.40%
Dec 31, 20191.43B-18.66%
Dec 31, 20181.76B15.03%
Dec 29, 20171.53B31.74%
Dec 30, 20161.16B-6.00%
Dec 31, 20151.24B-24.18%
Dec 31, 20141.63B-48.60%
Dec 31, 20133.18B81.10%
Dec 31, 20121.75B15.68%
Dec 30, 20111.52B16.20%
Dec 31, 20101.30B94.91%
Dec 31, 2009669.40M8.40%
Dec 31, 2008617.50M-35.48%
Dec 31, 2007957.00M-35.96%
Dec 29, 20061.49B30.34%
Dec 30, 20051.15B49.85%
Dec 31, 2004765.10M2.92%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Pharvaris 1.68B
Immunocore Holdings 1.67B
Harmony Biosciences Holdings 1.64B
Novavax 1.63B
Sionna Therapeutics 1.62B
Agios Pharmaceuticals 1.61B
Nanobiotix 1.61B
Oruka Therapeutics 1.60B
Market Cap Rankings